This page contains brief information about mogamulizumab-kpkc and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Mogamulizumab-kpkc is approved to treat:
- Mycosis fungoides or Sezary syndrome (types of cutaneous T-cell lymphoma). It is used to treat disease that has relapsed (come back) or is refractory (does not respond to treatment) in adult patients who have received at least one other type of systemic therapy.
Mogamulizumab-kpkc is also being studied in the treatment of other types of cancer.
More About Mogamulizumab-kpkc
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Mogamulizumab-kpkc - Check for trials from NCI's list of cancer clinical trials now accepting patients.